Cytoplasmic HMGB1 induces renal tubular ferroptosis after ischemia/reperfusion.

[1]  Ying Yao,et al.  Blocking connexin 43 and its promotion of ATP release from renal tubular epithelial cells ameliorates renal fibrosis , 2022, Cell death & disease.

[2]  D. Tang,et al.  The mechanism of HMGB1 secretion and release , 2022, Experimental & Molecular Medicine.

[3]  R. Deng,et al.  PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis , 2022, Nature Cell Biology.

[4]  J. Kellum,et al.  Acute kidney injury , 2021, Nature Reviews Disease Primers.

[5]  Yaqing Wang,et al.  The Cross-Link between Ferroptosis and Kidney Diseases , 2021, Oxidative medicine and cellular longevity.

[6]  Ying Zhao,et al.  HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose , 2021, Bioscience reports.

[7]  Yuanchen Cui,et al.  ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation , 2021, Brain, Behavior, and Immunity.

[8]  J. Loor,et al.  Identification of Milk Fat Metabolism-Related Pathways of the Bovine Mammary Gland during Mid and Late Lactation and Functional Verification of the ACSL4 Gene , 2020, Genes.

[9]  H. Pass,et al.  HMGB1 as a therapeutic target in disease , 2020, Journal of cellular physiology.

[10]  Ying Yao,et al.  XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury , 2020, Cell Death & Disease.

[11]  R. Bellomo,et al.  Acute kidney injury , 2019, The Lancet.

[12]  Peter J Cowan,et al.  Regulated necrosis in kidney ischemia-reperfusion injury. , 2019, Kidney international.

[13]  Cheng Yang,et al.  Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury , 2018, Cell Death & Disease.

[14]  J. Vince,et al.  Pyroptosis versus necroptosis: similarities, differences, and crosstalk , 2018, Cell Death & Differentiation.

[15]  Ying Yao,et al.  Pretreatment of Huaiqihuang extractum protects against cisplatin-induced nephrotoxicity , 2018, Scientific Reports.

[16]  L. Lv,et al.  Renal tubule injury: a driving force toward chronic kidney disease. , 2018, Kidney international.

[17]  Y. Lee,et al.  Plantago asiatica L. Ameliorates Puromycin Aminonucleoside-Induced Nephrotic Syndrome by Suppressing Inflammation and Apoptosis , 2017, Nutrients.

[18]  A. Sanz,et al.  Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI. , 2017, Journal of the American Society of Nephrology : JASN.

[19]  A. Walch,et al.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.

[20]  Simon C Watkins,et al.  Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. , 2017, Nature chemical biology.

[21]  R. Redfield,et al.  Improved renal ischemia tolerance in females influences kidney transplantation outcomes. , 2016, The Journal of clinical investigation.

[22]  J. Bonventre,et al.  Acute Kidney Injury. , 2016, Annual review of medicine.

[23]  H. Anders,et al.  Necroinflammation in Kidney Disease. , 2016, Journal of the American Society of Nephrology.

[24]  I. Kubota,et al.  High Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction. , 2015, Journal of atherosclerosis and thrombosis.

[25]  Xiaorong Zhu,et al.  Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. , 2015, The Journal of clinical investigation.

[26]  B. Ratliff,et al.  High mobility group box 1 is a novel deacetylation target of Sirtuin1 , 2014, Kidney international.

[27]  R. Schwabe,et al.  The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. , 2015, The Journal of clinical investigation.

[28]  Haichao Wang,et al.  HMGB1 in health and disease. , 2014, Molecular aspects of medicine.

[29]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[30]  E. Clayman,et al.  Protective Effect of Neutralization of the Extracellular High-Mobility Group Box 1 on Renal Ischemia-Reperfusion Injury in Miniature Swine , 2014, Transplantation.

[31]  D. Green,et al.  Synchronized renal tubular cell death involves ferroptosis , 2014, Proceedings of the National Academy of Sciences.

[32]  H. Anders,et al.  The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms. , 2014, Kidney international.

[33]  Junhua Li,et al.  Carbon monoxide potently prevents ischemia-induced high-mobility group box 1 translocation and release and protects against lethal renal ischemia-reperfusion injury. , 2014, Kidney international.

[34]  Z. Dong,et al.  Regulated cell death in AKI. , 2014, Journal of the American Society of Nephrology : JASN.

[35]  Xiaorong Zhu,et al.  Hepatocyte‐specific high‐mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: A role for intracellular high‐mobility group box 1 in cellular protection , 2014, Hepatology.

[36]  S. Chadban,et al.  Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice. , 2014, Kidney international.

[37]  R. Schwabe,et al.  High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. , 2014, Cell metabolism.

[38]  K. Nakao,et al.  Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure , 2013, Cardiovascular research.

[39]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[40]  K. Tracey,et al.  Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis , 2012, Arthritis Research & Therapy.

[41]  G. Kroemer,et al.  High-mobility group box 1 is essential for mitochondrial quality control. , 2011, Cell metabolism.

[42]  H. Koide,et al.  Hemoperfusion Treatment in a Septic Shock Patient with Autosomal Dominant Polycystic Kidney Disease and Increased HMGB1 Protein Levels , 2011, Blood Purification.

[43]  Q. Gong,et al.  Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  S. Chadban,et al.  HMGB1 contributes to kidney ischemia reperfusion injury. , 2010, Journal of the American Society of Nephrology : JASN.

[45]  I. Kubota,et al.  High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. , 2008, Cardiovascular research.

[46]  K. Tracey,et al.  High Mobility Group Box Protein-1 Correlates with Renal Function in Chronic Kidney Disease (CKD) , 2008, Molecular medicine.

[47]  J. Maman,et al.  Biochemical observation of the rapid mobility of nuclear HMGB1. , 2005, Biochimica et biophysica acta.

[48]  M. Gariboldi,et al.  Mapping of the Hmg1 gene and of seven related sequences in the mouse , 1995, Mammalian Genome.

[49]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[50]  T. M. Lewin,et al.  Expression and Characterization of Recombinant Rat Acyl-CoA Synthetases 1, 4, and 5 , 2001, The Journal of Biological Chemistry.

[51]  A. Aguzzi,et al.  The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.

[52]  M. Bustin,et al.  Serological analysis of species specificity in the high mobility group chromosomal proteins. , 1979, The Journal of biological chemistry.